Jun 22, 2026 09:05AM
May 27, 2026 07:30AM
May 27, 2026 07:30AM
May 12, 2026 07:30AM
May 12, 2026 07:30AM
May 11, 2026 09:31AM
May 11, 2026 09:30AM Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure
May 7, 2026 04:01PM
May 6, 2026 07:32AM
May 6, 2026 07:30AM
May 4, 2026 07:30AM
Mar 31, 2026 06:41AM
Mar 30, 2026 03:30PM
Mar 30, 2026 03:30PM Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54
Mar 30, 2026 09:50AM
Mar 30, 2026 07:31AM
Mar 30, 2026 07:30AM
Mar 12, 2026 09:24AM
Mar 11, 2026 02:00PM
Mar 11, 2026 02:00PM
Feb 24, 2026 04:01PM BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates
Feb 12, 2026 10:03AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 12, 2026 10:31AM
Jan 12, 2026 10:30AM
Dec 22, 2025 07:06AM
Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026
Nov 10, 2025 02:33AM
Nov 8, 2025 10:41AM
Oct 30, 2025 05:37AM
Oct 29, 2025 04:01PM
Oct 29, 2025 07:00AM
Oct 29, 2025 07:00AM
Oct 27, 2025 10:22AM BridgeBio Pharma (BBIO) PT Raised to $68 at Leerink Partners
Oct 27, 2025 07:00AM
Oct 27, 2025 07:00AM
Oct 24, 2025 08:29AM
Sep 28, 2025 11:15AM
Sep 6, 2025 02:30PM
Sep 6, 2025 02:30PM
Aug 30, 2025 07:15AM Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension
Aug 5, 2025 04:01PM
Jul 23, 2025 07:31AM
Jul 23, 2025 07:30AM
Jul 18, 2025 06:54AM
Jun 30, 2025 07:30AM
Jun 30, 2025 07:30AM
Jun 9, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
May 20, 2025 07:30AM

323,944 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All